메뉴 건너뛰기




Volumn 1, Issue 2, 2013, Pages 131-137

Hepatocellular carcinoma in non-alcoholic fatty liver disease: Epidemiology, pathogenesis, and prevention

Author keywords

Chemoprevention; Cirrhosis; Hepatocarcinogenesis; Insulin resistance; Lipotoxicity

Indexed keywords


EID: 84978914249     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2013.00005     Document Type: Review
Times cited : (44)

References (116)
  • 1
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–1231.
    • (2002) N Engl J Med , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 3
  • 4
    • 10644220306 scopus 로고    scopus 로고
    • Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
    • Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387–1395.
    • (2004) Hepatology , vol.40 , pp. 1387-1395
    • Browning, JD1    Szczepaniak, LS2    Dobbins, R3    Nuremberg, P4    Horton, JD5    Cohen, JC6
  • 6
    • 34247200322 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines
    • Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Nonalcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007;22:778–787.
    • (2007) J Gastroenterol Hepatol , vol.22 , pp. 778-787
    • Chitturi, S1    Farrell, GC2    Hashimoto, E3    Saibara, T4    Lau, GK5    Sollano, JD.6
  • 7
    • 84866531658 scopus 로고    scopus 로고
    • Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese
    • Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012;27:1555–1560.
    • (2012) J Gastroenterol Hepatol , vol.27 , pp. 1555-1560
    • Liu, CJ.1
  • 8
    • 84864081494 scopus 로고    scopus 로고
    • Features, diagnosis, and treatment of nonalcoholic fatty liver disease
    • Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10: 837–858.
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 837-858
    • Torres, DM1    Williams, CD2    Harrison, SA.3
  • 9
    • 77954315951 scopus 로고    scopus 로고
    • Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis
    • Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis 2010;211:182–186.
    • (2010) Atherosclerosis , vol.211 , pp. 182-186
    • Yilmaz, Y1    Kurt, R2    Yonal, O3    Polat, N4    Celikel, CA5    Gurdal, A6
  • 10
    • 53549112749 scopus 로고    scopus 로고
    • Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
    • Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008;51:1947–1953.
    • (2008) Diabetologia , vol.51 , pp. 1947-1953
    • Targher, G1    Marra, F2    Marchesini, G.3
  • 11
    • 84861197159 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in nonalcoholic fatty liver disease: An emerging menace
    • Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in nonalcoholic fatty liver disease: An emerging menace. J Hepatol 2012;56:1384–1391.
    • (2012) J Hepatol , vol.56 , pp. 1384-1391
    • Baffy, G1    Brunt, EM2    Caldwell, SH.3
  • 14
    • 63049133092 scopus 로고    scopus 로고
    • Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
    • Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485–1491.
    • (2009) J Clin Oncol , vol.27 , pp. 1485-1491
    • Altekruse, SF1    McGlynn, KA2    Reichman, ME.3
  • 15
    • 17044371509 scopus 로고    scopus 로고
    • Epidemiology of hepatocellular carcinoma
    • Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191–211.
    • (2005) Clin Liver Dis , vol.9 , pp. 191-211
    • Bosch, FX1    Ribes, J2    Cleries, R3    Diaz, M.4
  • 16
    • 43949086923 scopus 로고    scopus 로고
    • Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
    • Charlton M. Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain? Hepatology 2008;47:1431–1433.
    • (2008) Hepatology , vol.47 , pp. 1431-1433
    • Charlton, M.1
  • 17
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
    • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–2576.
    • (2007) Gastroenterology , vol.132 , pp. 2557-2576
    • El-Serag, HB1    Rudolph, KL.2
  • 18
    • 0034791598 scopus 로고    scopus 로고
    • The spectrum of liver disease in the general population: lesson from the Dionysos study
    • Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001;35:531–537.
    • (2001) J Hepatol , vol.35 , pp. 531-537
    • Bellentani, S1    Tiribelli, C.2
  • 20
    • 33750617920 scopus 로고    scopus 로고
    • Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    • Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874–880.
    • (2006) Hepatology , vol.44 , pp. 874-880
    • Merriman, RB1    Ferrell, LD2    Patti, MG3    Weston, SR4    Pabst, MS5    Aouizerat, BE6
  • 22
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
    • Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124–131.
    • (2011) Gastroenterology , vol.140 , pp. 124-131
    • Williams, CD1    Stengel, J2    Asike, MI3    Torres, DM4    Shaw, J5    Contreras, M6
  • 23
    • 84055193440 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?
    • Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res 2012;42: 1–14.
    • (2012) Hepatol Res , vol.42 , pp. 1-14
    • Hashimoto, E1    Tokushige, K.2
  • 24
    • 33645963121 scopus 로고    scopus 로고
    • Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
    • Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006;43:682–689.
    • (2006) Hepatology , vol.43 , pp. 682-689
    • Sanyal, AJ1    Banas, C2    Sargeant, C3    Luketic, VA4    Sterling, RK5    Stravitz, RT6
  • 25
    • 77952730428 scopus 로고    scopus 로고
    • The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    • Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010;51:1972–1978.
    • (2010) Hepatology , vol.51 , pp. 1972-1978
    • Ascha, MS1    Hanouneh, IA2    Lopez, R3    Tamimi, TA4    Feldstein, AF5    Zein, NN.6
  • 26
    • 58849132440 scopus 로고    scopus 로고
    • Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
    • Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009;24:248–254.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 248-254
    • Yatsuji, S1    Hashimoto, E2    Tobari, M3    Taniai, M4    Tokushige, K5    Shiratori, K.6
  • 27
    • 84984548367 scopus 로고    scopus 로고
    • Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan
    • Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008;135:111–121.
    • (2008) Gastroenterology , vol.135 , pp. 111-121
    • Chen, CL1    Yang, HI2    Yang, WS3    Liu, CJ4    Chen, PJ5    You, SL6
  • 29
    • 0033019013 scopus 로고    scopus 로고
    • Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
    • Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664–669.
    • (1999) Hepatology , vol.29 , pp. 664-669
    • Caldwell, SH1    Oelsner, DH2    Iezzoni, JC3    Hespenheide, EE4    Battle, EH5    Driscoll, CJ.6
  • 30
    • 0033797838 scopus 로고    scopus 로고
    • Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study
    • Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32:689–692.
    • (2000) Hepatology , vol.32 , pp. 689-692
    • Poonawala, A1    Nair, SP2    Thuluvath, PJ.3
  • 31
    • 0036894480 scopus 로고    scopus 로고
    • NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
    • Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349–1354.
    • (2002) Hepatology , vol.36 , pp. 1349-1354
    • Marrero, JA1    Fontana, RJ2    Su, GL3    Conjeevaram, HS4    Emick, DM5    Lok, AS.6
  • 32
    • 84857947511 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
    • Torres DM, Harrison SA. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 2012;32:30–38.
    • (2012) Semin Liver Dis , vol.32 , pp. 30-38
    • Torres, DM1    Harrison, SA.2
  • 33
    • 77955625142 scopus 로고    scopus 로고
    • Population-based risk factors and resource utilization for HCC: US perspective
    • Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010;26:2183–2191.
    • (2010) Curr Med Res Opin , vol.26 , pp. 2183-2191
    • Sanyal, A1    Poklepovic, A2    Moyneur, E3    Barghout, V.4
  • 34
    • 84876557053 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease without cirrhosis is an emergent and independent risk factor of hepatocellular carcinoma: A population based study
    • Rahman RN, Ibdah JA. Nonalcoholic fatty liver disease without cirrhosis is an emergent and independent risk factor of hepatocellular carcinoma: A population based study. Hepatology 2012;56:241A.
    • (2012) Hepatology , vol.56 , pp. 241A
    • Rahman, RN1    Ibdah, JA.2
  • 35
    • 84856736177 scopus 로고    scopus 로고
    • Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma
    • Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol 2012;107:253–261.
    • (2012) Am J Gastroenterol , vol.107 , pp. 253-261
    • Kawamura, Y1    Arase, Y2    Ikeda, K3    Seko, Y4    Imai, N5    Hosaka, T6
  • 36
    • 84869436442 scopus 로고    scopus 로고
    • Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review
    • e2
    • White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012;10:1342–1359.e2.
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 1342-1359
    • White, DL1    Kanwal, F2    El-Serag, HB.3
  • 37
    • 77957200500 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications
    • Stickel F, Hellerbrand C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut 2010;59: 1303–1307.
    • (2010) Gut , vol.59 , pp. 1303-1307
    • Stickel, F1    Hellerbrand, C.2
  • 38
    • 77951456114 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection
    • Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010;51: 1820–1832.
    • (2010) Hepatology , vol.51 , pp. 1820-1832
    • Starley, BQ1    Calcagno, CJ2    Harrison, SA.3
  • 39
    • 7044272630 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in cirrhosis: incidence and risk factors
    • Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35–50.
    • (2004) Gastroenterology , vol.127 , pp. S35-S50
    • Fattovich, G1    Stroffolini, T2    Zagni, I3    Donato, F.4
  • 40
    • 0037464510 scopus 로고    scopus 로고
    • Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
    • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–1638.
    • (2003) N Engl J Med , vol.348 , pp. 1625-1638
    • Calle, EE1    Rodriguez, C2    Walker-Thurmond, K3    Thun, MJ.4
  • 41
    • 38949108241 scopus 로고    scopus 로고
    • Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
    • Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–578.
    • (2008) Lancet , vol.371 , pp. 569-578
    • Renehan, AG1    Tyson, M2    Egger, M3    Heller, RF4    Zwahlen, M.5
  • 42
    • 78149386734 scopus 로고    scopus 로고
    • Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets
    • Severi T, van Malenstein H, Verslype C, van Pelt JF. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin 2010;31:1409–1420.
    • (2010) Acta Pharmacol Sin , vol.31 , pp. 1409-1420
    • Severi, T1    van Malenstein, H2    Verslype, C3    van Pelt, JF.4
  • 43
    • 0036699940 scopus 로고    scopus 로고
    • Molecular pathogenesis of human hepatocellular carcinoma
    • Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339–346.
    • (2002) Nat Genet , vol.31 , pp. 339-346
    • Thorgeirsson, SS1    Grisham, JW.2
  • 44
    • 33747830764 scopus 로고    scopus 로고
    • Hepatocellular carcinoma pathogenesis: from genes to environment
    • Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006;6:674–687.
    • (2006) Nat Rev Cancer , vol.6 , pp. 674-687
    • Farazi, PA1    DePinho, RA.2
  • 45
    • 84857652096 scopus 로고    scopus 로고
    • Role of the microenvironment in hepatocellular carcinoma development and progression
    • Wu SD, Ma YS, Fang Y, Liu LL, Fu D, Shen XZ. Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev 2012;38:218–225.
    • (2012) Cancer Treat Rev , vol.38 , pp. 218-225
    • Wu, SD1    Ma, YS2    Fang, Y3    Liu, LL4    Fu, D5    Shen, XZ.6
  • 46
    • 33845790499 scopus 로고    scopus 로고
    • A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
    • Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006;131: 1758–1767.
    • (2006) Gastroenterology , vol.131 , pp. 1758-1767
    • Llovet, JM1    Chen, Y2    Wurmbach, E3    Roayaie, S4    Fiel, MI5    Schwartz, M6
  • 47
    • 0033765496 scopus 로고    scopus 로고
    • Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis– A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma
    • Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis– A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 2000;32:970–979.
    • (2000) Hepatology , vol.32 , pp. 970-979
    • Kondo, Y1    Kanai, Y2    Sakamoto, M3    Mizokami, M4    Ueda, R5    Hirohashi, S.6
  • 48
    • 78649266473 scopus 로고    scopus 로고
    • Signaling networks in human hepatocarcinogenesis–novel aspects and therapeutic options
    • Breuhahn K, Schirmacher P. Signaling networks in human hepatocarcinogenesis–novel aspects and therapeutic options. Prog Mol Biol Transl Sci 2010;97:251–277.
    • (2010) Prog Mol Biol Transl Sci , vol.97 , pp. 251-277
    • Breuhahn, K1    Schirmacher, P.2
  • 49
    • 33846463379 scopus 로고    scopus 로고
    • Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
    • Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007;45:42–52.
    • (2007) Hepatology , vol.45 , pp. 42-52
    • Boyault, S1    Rickman, DS2    de Reynies, A3    Balabaud, C4    Rebouissou, S5    Jeannot, E6
  • 50
    • 77349092851 scopus 로고    scopus 로고
    • Molecular classification and novel targets in hepatocellular carcinoma: recent advancements
    • Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010;30:35–51.
    • (2010) Semin Liver Dis , vol.30 , pp. 35-51
    • Hoshida, Y1    Toffanin, S2    Lachenmayer, A3    Villanueva, A4    Minguez, B5    Llovet, JM.6
  • 51
    • 33745552897 scopus 로고    scopus 로고
    • Dysregulation of growth factor signaling in human hepatocellular carcinoma
    • Breuhahn K, Longerich T, Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 2006;25: 3787–3800.
    • (2006) Oncogene , vol.25 , pp. 3787-3800
    • Breuhahn, K1    Longerich, T2    Schirmacher, P.3
  • 52
    • 84864480565 scopus 로고    scopus 로고
    • Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives
    • Zhu AX. Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives. Semin Oncol 2012; 39:493–502.
    • (2012) Semin Oncol , vol.39 , pp. 493-502
    • Zhu, AX.1
  • 53
    • 84877673233 scopus 로고    scopus 로고
    • A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinoma
    • Chen X, Ding G, Gao Q, Sun J, Zhang Q, Du L, et al. A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinoma. PLoS One 2013;8:e63093.
    • (2013) PLoS One , vol.8 , pp. e63093
    • Chen, X1    Ding, G2    Gao, Q3    Sun, J4    Zhang, Q5    Du, L6
  • 54
    • 46349103001 scopus 로고    scopus 로고
    • Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
    • Bengochea A, de Souza MM, Lefrancois L, Le Roux E, Galy O, Chemin I, et al. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 2008;99:143–150.
    • (2008) Br J Cancer , vol.99 , pp. 143-150
    • Bengochea, A1    de Souza, MM2    Lefrancois, L3    Le Roux, E4    Galy, O5    Chemin, I6
  • 55
    • 79959996152 scopus 로고    scopus 로고
    • A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma
    • Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, et al. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 2011; 141:141–149.
    • (2011) Gastroenterology , vol.141 , pp. 141-149
    • Abu Dayyeh, BK1    Yang, M2    Fuchs, BC3    Karl, DL4    Yamada, S5    Sninsky, JJ6
  • 56
    • 38949184246 scopus 로고    scopus 로고
    • Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
    • Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008;14: 419–427.
    • (2008) Clin Cancer Res , vol.14 , pp. 419-427
    • Jiang, J1    Gusev, Y2    Aderca, I3    Mettler, TA4    Nagorney, DM5    Brackett, DJ6
  • 57
    • 58149386462 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression
    • Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, et al. Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 2008;48:1810–1820.
    • (2008) Hepatology , vol.48 , pp. 1810-1820
    • Cheung, O1    Puri, P2    Eicken, C3    Contos, MJ4    Mirshahi, F5    Maher, JW6
  • 58
    • 34247857663 scopus 로고    scopus 로고
    • Obesity, inflammation, and insulin resistance
    • Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169–2180.
    • (2007) Gastroenterology , vol.132 , pp. 2169-2180
    • Shoelson, SE1    Herrero, L2    Naaz, A.3
  • 59
    • 33845866857 scopus 로고    scopus 로고
    • Inflammation and metabolic disorders
    • Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444: 860–867.
    • (2006) Nature , vol.444 , pp. 860-867
    • Hotamisligil, GS.1
  • 60
    • 49649096375 scopus 로고    scopus 로고
    • Visceral fat: a key mediator of steatohepatitis in metabolic liver disease
    • Van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008;48:449–457.
    • (2008) Hepatology , vol.48 , pp. 449-457
    • Van der Poorten, D1    Milner, KL2    Hui, J3    Hodge, A4    Trenell, MI5    Kench, JG6
  • 62
    • 34047250349 scopus 로고    scopus 로고
    • Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells
    • Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 2007;67:2497–2507.
    • (2007) Cancer Res , vol.67 , pp. 2497-2507
    • Saxena, NK1    Sharma, D2    Ding, X3    Lin, S4    Marra, F5    Merlin, D6
  • 63
    • 84866079242 scopus 로고    scopus 로고
    • The role of adiponectin in cancer: a review of current evidence
    • Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev 2012;33:547–594.
    • (2012) Endocr Rev , vol.33 , pp. 547-594
    • Dalamaga, M1    Diakopoulos, KN2    Mantzoros, CS.3
  • 64
    • 74549167737 scopus 로고    scopus 로고
    • Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression
    • Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010;140:197–208.
    • (2010) Cell , vol.140 , pp. 197-208
    • Park, EJ1    Lee, JH2    Yu, GY3    He, G4    Ali, SR5    Holzer, RG6
  • 65
    • 0033694535 scopus 로고    scopus 로고
    • Lipotoxic diseases of nonadipose tissues in obesity
    • (Suppl)
    • Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000;24 (Suppl):28–32.
    • (2000) Int J Obes Relat Metab Disord , vol.24 , pp. 28-32
    • Unger, RH1    Orci, L.2
  • 66
    • 53849143606 scopus 로고    scopus 로고
    • Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese
    • Tan CY, Vidal-Puig A. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 2008;36:935–940.
    • (2008) Biochem Soc Trans , vol.36 , pp. 935-940
    • Tan, CY1    Vidal-Puig, A.2
  • 67
    • 4043077961 scopus 로고    scopus 로고
    • Molecular mediators of hepatic steatosis and liver injury
    • Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147–152.
    • (2004) J Clin Invest , vol.114 , pp. 147-152
    • Browning, JD1    Horton, JD.2
  • 68
    • 38649116056 scopus 로고    scopus 로고
    • Selective versus total insulin resistance: a pathogenic paradox
    • Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008;7:95–96.
    • (2008) Cell Metab , vol.7 , pp. 95-96
    • Brown, MS1    Goldstein, JL.2
  • 69
    • 40549135297 scopus 로고    scopus 로고
    • Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
    • Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829–838.
    • (2008) J Clin Invest , vol.118 , pp. 829-838
    • Postic, C1    Girard, J.2
  • 71
    • 70349249503 scopus 로고    scopus 로고
    • Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
    • Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009;50: 772–780.
    • (2009) Hepatology , vol.50 , pp. 772-780
    • Fujita, K1    Nozaki, Y2    Wada, K3    Yoneda, M4    Fujimoto, Y5    Fujitake, M6
  • 74
    • 77950233673 scopus 로고    scopus 로고
    • A fresh look at NASH pathogenesis. Part 1: The metabolic movers
    • Larter CZ, Chitturi S, Heydet D, Farrell GC. A fresh look at NASH pathogenesis. Part 1: The metabolic movers. J Gastroenterol Hepatol 2010;25:672–690.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 672-690
    • Larter, CZ1    Chitturi, S2    Heydet, D3    Farrell, GC.4
  • 75
    • 43249092409 scopus 로고    scopus 로고
    • Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
    • Choi SS, Diehl AM. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol 2008;19:295–300.
    • (2008) Curr Opin Lipidol , vol.19 , pp. 295-300
    • Choi, SS1    Diehl, AM.2
  • 76
    • 70049089646 scopus 로고    scopus 로고
    • Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
    • Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol 2009;3:445–451.
    • (2009) Expert Rev Gastroenterol Hepatol , vol.3 , pp. 445-451
    • Alkhouri, N1    Dixon, LJ2    Feldstein, AE.3
  • 77
    • 43949144276 scopus 로고    scopus 로고
    • Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders
    • Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, et al. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology 2008; 47:1513–1523.
    • (2008) Hepatology , vol.47 , pp. 1513-1523
    • Johnson, NA1    Walton, DW2    Sachinwalla, T3    Thompson, CH4    Smith, K5    Ruell, PA6
  • 78
    • 77955851425 scopus 로고    scopus 로고
    • Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy
    • Van Werven JR, Schreuder TC, Nederveen AJ, Lavini C, Jansen PL, Stoker J. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy. Eur J Radiol 2010;75:e102–e107.
    • (2010) Eur J Radiol , vol.75 , pp. e102-e107
    • Van Werven, JR1    Schreuder, TC2    Nederveen, AJ3    Lavini, C4    Jansen, PL5    Stoker, J.6
  • 79
    • 33744948514 scopus 로고    scopus 로고
    • Free fatty acids induce JNKdependent hepatocyte lipoapoptosis
    • Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNKdependent hepatocyte lipoapoptosis. J Biol Chem 2006;281:12093–12101.
    • (2006) J Biol Chem , vol.281 , pp. 12093-12101
    • Malhi, H1    Bronk, SF2    Werneburg, NW3    Gores, GJ.4
  • 80
    • 77649132053 scopus 로고    scopus 로고
    • Mechanisms and clinical implications of hepatocyte lipoapoptosis
    • Cazanave SC, Gores GJ. Mechanisms and clinical implications of hepatocyte lipoapoptosis. Clin Lipidol 2010;5:71–85.
    • (2010) Clin Lipidol , vol.5 , pp. 71-85
    • Cazanave, SC1    Gores, GJ.2
  • 82
    • 33750584214 scopus 로고    scopus 로고
    • TLR4 links innate immunity and fatty acid-induced insulin resistance
    • Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116: 3015–3025.
    • (2006) J Clin Invest , vol.116 , pp. 3015-3025
    • Shi, H1    Kokoeva, MV2    Inouye, K3    Tzameli, I4    Yin, H5    Flier, JS.6
  • 83
    • 21244472975 scopus 로고    scopus 로고
    • IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
    • Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977–990.
    • (2005) Cell , vol.121 , pp. 977-990
    • Maeda, S1    Kamata, H2    Luo, JL3    Leffert, H4    Karin, M.5
  • 84
    • 84856429876 scopus 로고    scopus 로고
    • Obesity, inflammation, and liver cancer
    • Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol 2012;56: 704–713.
    • (2012) J Hepatol , vol.56 , pp. 704-713
    • Sun, B1    Karin, M.2
  • 85
    • 0035856949 scopus 로고    scopus 로고
    • Insulin signalling and the regulation of glucose and lipid metabolism
    • Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799–806.
    • (2001) Nature , vol.414 , pp. 799-806
    • Saltiel, AR1    Kahn, CR.2
  • 86
    • 3543072186 scopus 로고    scopus 로고
    • Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
    • Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579–591.
    • (2004) Nat Rev Cancer , vol.4 , pp. 579-591
    • Calle, EE1    Kaaks, R.2
  • 87
    • 81855225795 scopus 로고    scopus 로고
    • Molecular mechanisms of cancer development in obesity
    • Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011;11:886–895.
    • (2011) Nat Rev Cancer , vol.11 , pp. 886-895
    • Khandekar, MJ1    Cohen, P2    Spiegelman, BM.3
  • 88
    • 85179150566 scopus 로고    scopus 로고
    • Effect of regular training on hepatocellular carcinoma development in hepatocyte-specific PTEN-deficient mice
    • Piguet AC. Effect of regular training on hepatocellular carcinoma development in hepatocyte-specific PTEN-deficient mice. International Liver Congress Amsterdam, 2013.
    • (2013) International Liver Congress Amsterdam
    • Piguet, AC.1
  • 89
    • 79551510805 scopus 로고    scopus 로고
    • Obesity and cancer risk: recent review and evidence
    • Basen-Engquist K, Chang M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 2011;13:71–76.
    • (2011) Curr Oncol Rep , vol.13 , pp. 71-76
    • Basen-Engquist, K1    Chang, M.2
  • 91
    • 84873990663 scopus 로고    scopus 로고
    • Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery
    • Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219–234.
    • (2013) J Intern Med , vol.273 , pp. 219-234
    • Sjostrom, L.1
  • 92
    • 84868304332 scopus 로고    scopus 로고
    • PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals
    • Burza MA. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. Dig Liver Dis 2012;44: 1037–1041.
    • (2012) Dig Liver Dis , vol.44 , pp. 1037-1041
    • Burza, MA.1
  • 93
    • 77954365681 scopus 로고    scopus 로고
    • Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
    • Donadon V, Balbi M, Mas MD, Casarin P, Zanette G. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int 2010;30:750–758.
    • (2010) Liver Int , vol.30 , pp. 750-758
    • Donadon, V1    Balbi, M2    Mas, MD3    Casarin, P4    Zanette, G.5
  • 94
    • 79961216168 scopus 로고    scopus 로고
    • Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients
    • Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab 2011;96:2601–2608.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 2601-2608
    • Nkontchou, G1    Cosson, E2    Aout, M3    Mahmoudi, A4    Bourcier, V5    Charif, I6
  • 95
    • 77951006620 scopus 로고    scopus 로고
    • Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
    • Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 2010;116:1938–1946.
    • (2010) Cancer , vol.116 , pp. 1938-1946
    • Hassan, MM1    Curley, SA2    Li, D3    Kaseb, A4    Davila, M5    Abdalla, EK6
  • 96
    • 84855432249 scopus 로고    scopus 로고
    • Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: A population-based cohort study
    • Lai S-W, Chen P-C, Liao K-F, Muo C-H, Lin C-C, Sung F-C. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: A population-based cohort study. Am J Gastroenterol 2011;107:46–52.
    • (2011) Am J Gastroenterol , vol.107 , pp. 46-52
    • Lai, S-W1    Chen, P-C2    Liao, K-F3    Muo, C-H4    Lin, C-C5    Sung, F-C.6
  • 97
    • 84874660234 scopus 로고    scopus 로고
    • Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
    • Chen HP, Shieh JJ, Chang CC, Chen TT, Lin JT, Wu MS, et al. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut 2013;62:606–615.
    • (2013) Gut , vol.62 , pp. 606-615
    • Chen, HP1    Shieh, JJ2    Chang, CC3    Chen, TT4    Lin, JT5    Wu, MS6
  • 98
    • 84864072013 scopus 로고    scopus 로고
    • Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis
    • Bhalla K, Hwang BJ, Dewi RE, Twaddel W, Goloubeva OG, Wong KK, et al. Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila) 2012;5:544–552.
    • (2012) Cancer Prev Res (Phila) , vol.5 , pp. 544-552
    • Bhalla, K1    Hwang, BJ2    Dewi, RE3    Twaddel, W4    Goloubeva, OG5    Wong, KK6
  • 99
    • 84863601615 scopus 로고    scopus 로고
    • Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and metaanalysis
    • Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and metaanalysis. J Clin Endocrinol Metab 2012;97:2347–2353.
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 2347-2353
    • Zhang, ZJ1    Zheng, ZJ2    Shi, R3    Su, Q4    Jiang, Q5    Kip, KE.6
  • 100
    • 84868156060 scopus 로고    scopus 로고
    • Functional role of peroxisome-proliferatoractivated receptor gamma in hepatocellular carcinoma
    • Wu CW, Farrell GC, Yu J. Functional role of peroxisome-proliferatoractivated receptor gamma in hepatocellular carcinoma. J Gastroenterol Hepatol 2012;27:1665–1669.
    • (2012) J Gastroenterol Hepatol , vol.27 , pp. 1665-1669
    • Wu, CW1    Farrell, GC2    Yu, J.3
  • 101
    • 78651335893 scopus 로고    scopus 로고
    • Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs
    • Okumura T. Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs. J Gastroenterol 2010;45:1097–1102.
    • (2010) J Gastroenterol , vol.45 , pp. 1097-1102
    • Okumura, T.1
  • 102
    • 84881491358 scopus 로고    scopus 로고
    • Statins are associated with a reduced risk of hepatocellular cancer: A systematic review and metaanalysis
    • Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Statins are associated with a reduced risk of hepatocellular cancer: A systematic review and metaanalysis. Gastroenterology 2013;144:323–332.
    • (2013) Gastroenterology , vol.144 , pp. 323-332
    • Singh, S1    Singh, PP2    Singh, AG3    Murad, MH4    Sanchez, W.5
  • 103
    • 79952764351 scopus 로고    scopus 로고
    • MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase
    • Cao Z, Fan-Minogue H, Bellovin DI, Yevtodiyenko A, Arzeno J, Yang Q, et al. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res 2011;71: 2286–2297.
    • (2011) Cancer Res , vol.71 , pp. 2286-2297
    • Cao, Z1    Fan-Minogue, H2    Bellovin, DI3    Yevtodiyenko, A4    Arzeno, J5    Yang, Q6
  • 105
    • 55549144718 scopus 로고    scopus 로고
    • FXR: a metabolic regulator and cell protector
    • Wang YD, Chen WD, Moore DD, Huang W. FXR: a metabolic regulator and cell protector. Cell Res 2008;18:1087–1095.
    • (2008) Cell Res , vol.18 , pp. 1087-1095
    • Wang, YD1    Chen, WD2    Moore, DD3    Huang, W.4
  • 106
    • 33645821043 scopus 로고    scopus 로고
    • Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration
    • Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006;312:233–236.
    • (2006) Science , vol.312 , pp. 233-236
    • Huang, W1    Ma, K2    Zhang, J3    Qatanani, M4    Cuvillier, J5    Liu, J6
  • 107
    • 57149118460 scopus 로고    scopus 로고
    • Nuclear bile acid receptor FXR protects against intestinal tumorigenesis
    • Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res 2008; 68:9589–9594.
    • (2008) Cancer Res , vol.68 , pp. 9589-9594
    • Modica, S1    Murzilli, S2    Salvatore, L3    Schmidt, DR4    Moschetta, A.5
  • 108
    • 84867305638 scopus 로고    scopus 로고
    • FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model
    • Deuschle U, Schuler J, Schulz A, Schluter T, Kinzel O, Abel U, et al. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model. PLoS One 2012;7:e43044.
    • (2012) PLoS One , vol.7 , pp. e43044
    • Deuschle, U1    Schuler, J2    Schulz, A3    Schluter, T4    Kinzel, O5    Abel, U6
  • 109
    • 79959491395 scopus 로고    scopus 로고
    • Increased activation of the Wnt/beta-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice
    • Wolfe A, Thomas A, Edwards G, Jaseja R, Guo GL, Apte U. Increased activation of the Wnt/beta-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice. J Pharmacol Exp Ther 2011;338:12–21.
    • (2011) J Pharmacol Exp Ther , vol.338 , pp. 12-21
    • Wolfe, A1    Thomas, A2    Edwards, G3    Jaseja, R4    Guo, GL5    Apte, U.6
  • 110
    • 84874503997 scopus 로고    scopus 로고
    • Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer
    • Jiang Y, Iakova P, Jin J, Sullivan E, Sharin V, Hong IH, et al. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 2013;57:1098–1106.
    • (2013) Hepatology , vol.57 , pp. 1098-1106
    • Jiang, Y1    Iakova, P2    Jin, J3    Sullivan, E4    Sharin, V5    Hong, IH6
  • 111
    • 16544371307 scopus 로고    scopus 로고
    • The epidemiology of alcoholic liver disease
    • Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003;27:209–219.
    • (2003) Alcohol Res Health , vol.27 , pp. 209-219
    • Mann, RE1    Smart, RG2    Govoni, R.3
  • 112
    • 84862743466 scopus 로고    scopus 로고
    • Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study
    • Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 2012;156:841–847.
    • (2012) Ann Intern Med , vol.156 , pp. 841-847
    • Jepsen, P1    Ott, P2    Andersen, PK3    Sorensen, HT4    Vilstrup, H.5
  • 113
    • 44949096255 scopus 로고    scopus 로고
    • Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management
    • Fung J, Lai CL, But D, Wong D, Cheung TK, Yuen MF. Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management. Am J Gastroenterol 2008;103:1421–1426.
    • (2008) Am J Gastroenterol , vol.103 , pp. 1421-1426
    • Fung, J1    Lai, CL2    But, D3    Wong, D4    Cheung, TK5    Yuen, MF.6
  • 114
    • 33644506166 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005
    • Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006;43:S173–181.
    • (2006) Hepatology , vol.43 , pp. S173-S181
    • Yim, HJ1    Lok, AS.2
  • 115
    • 0033584440 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    • Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556–562.
    • (1999) N Engl J Med , vol.341 , pp. 556-562
    • Alter, MJ1    Kruszon-Moran, D2    Nainan, OV3    McQuillan, GM4    Gao, F5    Moyer, LA6
  • 116
    • 17344370538 scopus 로고    scopus 로고
    • Prognosis of chronic hepatitis C: results of a large, prospective cohort study
    • Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998;28:1687–1695.
    • (1998) Hepatology , vol.28 , pp. 1687-1695
    • Niederau, C1    Lange, S2    Heintges, T3    Erhardt, A4    Buschkamp, M5    Hurter, D6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.